Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 481 AL 495

Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol

König A, Linz N, Baykara E, Tröger J, Ritchie C, Saunders S, Teipel S, Köhler S, Sánchez-Benavides G, Grau-Rivera O, Gispert JD, Palmqvist S, Tideman P, Hansson O.

J Prev Alzheimers Dis. 2023;10(2):314-321. doi: 10.14283/jpad.2023.11.

Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum

Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M, Vivien D, de La Sayette V, Chételat G; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2023 Jun 13;100(24):e2454-e2465. doi: 10.1212/WNL.0000000000207338. Epub 2023 Apr 21.

Methodological flaws in"diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis"

Hsu YP, Hsu CW, Chen LF, Liu YK.

Ageing Res Rev. 2023 Jul;88:101938. doi: 10.1016/j.arr.2023.101938. Epub 2023 Apr 23.

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Lewy Body Dementias Prodromal Working Group.

Alzheimers Dement. 2023 Jul;19(7):3186-3202. doi: 10.1002/alz.13105. Epub 2023 Apr 24.

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C.

Mol Psychiatry. 2023 Jul;28(7):2716-2727. doi: 10.1038/s41380-023-02076-1. Epub 2023 May 2.

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta-analysis

García-García I, Fernández-Andújar M, Narváez M, García-Casares N.

Obes Rev. 2023 Aug;24(8):e13573. doi: 10.1111/obr.13573. Epub 2023 May 10.

GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Cells. 2023 May 4;12(9):1309. doi: 10.3390/cells12091309.

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis

Zabala-Findlay A, Penny LK, Lofthouse RA, Porter AJ, Palliyil S, Harrington CR, Wischik CM, Arastoo M.

Cells. 2023 Apr 18;12(8):1184. doi: 10.3390/cells12081184.

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Hansson O, Blennow K, Zetterberg H, Dage J.

Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3. Epub 2023 May 18.

Detection and treatment of Alzheimer's disease in its preclinical stage

Rafii MS, Aisen PS.

Nat Aging. 2023 May;3(5):520-531. doi: 10.1038/s43587-023-00410-4. Epub 2023 May 18.

Co-twin design in brain imaging-review on biomarkers of Alzheimer's disease

Varjonen A, Schwarz C, Vuoksimaa E.

Cereb Cortex. 2023 Jul 5;33(14):9054-9066. doi: 10.1093/cercor/bhad181.

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Papaliagkas V, Kalinderi K, Vareltzis P, Moraitou D, Papamitsou T, Chatzidimitriou M.

Int J Mol Sci. 2023 May 19;24(10):8976. doi: 10.3390/ijms24108976.

Comparing three neuropsychological subgrouping approaches in subjective and mild cognitive impairment from a naturalistic multicenter study

Rennie A, Ekman U, Wallert J, Muehlboeck JS, Eriksdotter M, Wahlund LO, Ferreira D, Westman E.

Neurobiol Aging. 2023 Sep;129:41-49. doi: 10.1016/j.neurobiolaging.2023.04.008. Epub 2023 Apr 25.

Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis

Zhou F, Sun Y, Xie X, Zhao Y.

Alzheimers Res Ther. 2023 Jun 8;15(1):107. doi: 10.1186/s13195-023-01254-1.

Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape

Hampel H, Hu Y, Cummings J, Mattke S, Iwatsubo T, Nakamura A, Vellas B, O'Bryant S, Shaw LM, Cho M, Batrla R, Vergallo A, Blennow K, Dage J, Schindler SE.

Neuron. 2023 Sep 20;111(18):2781-2799. doi: 10.1016/j.neuron.2023.05.017. Epub 2023 Jun 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias